Gary C. Peters sold Organon & Co (NYSE: OGN)
Gary C. Peters (D-MI), a U.S. Senator, has disclosed 1 trade in Organon & Co (OGN) since 2025, a single sale, worth an estimated $8K in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts).
The trade highlighted here is a sale: Gary C. Peters sold $1,001 - $15,000 of Organon & Co (NYSE: OGN) on July 10, 2025. Since that trade, OGN is up +35.32% against the S&P 500 up +19.53%, an outperformance of +15.79%.
Data updated
Gary C. Peters's OGN trades vs the price
OGN is up +35.32% since Gary C. Peters sold on July 10, 2025, versus +19.53% for the S&P 500.
Performance since this trade
All Gary C. Peters OGN trades
Gary C. Peters & OGN trading FAQ
Is it legal for Gary C. Peters to trade Organon & Co (OGN) stock?
Yes. Members of Congress are allowed to trade individual stocks, including Organon & Co (OGN), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. BullishWhales tracks those disclosures; this page does not imply the trade was improper.
When did Gary C. Peters sell OGN?
Gary C. Peters disclosed a sale of $1,001 - $15,000 of Organon & Co (OGN) on July 10, 2025, according to public STOCK Act filings.
How has OGN performed since Gary C. Peters's trade?
Since Gary C. Peters sold OGN on July 10, 2025, the stock is up +35.32%, versus +19.53% for the S&P 500 over the same period, an outperformance of +15.79%.
How soon must members of Congress disclose a trade?
Under the STOCK Act, members of Congress must publicly report a covered transaction within 45 days of the trade. Filings can still be delayed, amended, or contain errors.
Where can I see all congressional OGN trades?
BullishWhales tracks every disclosed congressional trade in Organon & Co (OGN) on the Organon & Co congressional trading page, which aggregates filings across all members of Congress.
Gary C. Peters's OGN tradesAll congressional filings for Organon & CoGary C. Peters's full profile
Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. Estimated prices and post-trade returns are derived algorithmically from public filings and end-of-day market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.